InvestorX
SEDAR® Issuer number:
00024061
Company name:
iCo Therapeutics Inc.
Document type:
ON Form 13-502F1 (Class 1 and 3B Reporting Issuers - Participation Fee)
Project number:
03213274
Filing date:
04-29-2021